Literature DB >> 22350461

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

Tetsu Akimoto1, Kazuhiro Shiizaki, Taro Sugase, Yuko Watanabe, Hiromichi Yoshizawa, Naoko Otani, Akihiko Numata, Eri Takeshima, Tomoyuki Yamazaki, Takuya Miki, Chiharu Ito, Johanne V Pastor, Yoshitaka Iwazu, Osamu Saito, Shigeaki Muto, Makoto Kuro-o, Eiji Kusano.   

Abstract

BACKGROUND: Klotho has been investigated as an anti-aging protein that is predominantly expressed in the distal convoluted tubules in the kidneys and in the choroid plexus of the brain. The purpose of the present study was to determine the relationship between the soluble form of Klotho and renal function in chronic peritoneal dialysis (PD) patients, a relationship which remains poorly understood.
METHODS: The soluble Klotho levels in the serum, urine, and peritoneal dialysate obtained from thirty-six PD patients were determined by a sandwich enzyme-linked immunosorbent assay system.
RESULTS: The amount of urinary excreted soluble Klotho over 24 h ranged from 1.54 to 1774.4 ng/day (median 303.2 ng/day; interquartile range [IR] 84.1-498.5), while the serum soluble Klotho concentration ranged from 194.4 to 990.4 pg/ml (mean 553.7 ± 210.4 pg/ml). The amount of urinary Klotho excretion was significantly correlated with residual renal function. However, there was no apparent correlation between the serum soluble Klotho levels and the residual renal function. Klotho was also detected in the 24-h dialysate collections. There was a significant correlation between the peritoneal Klotho excretion and the amount of albumin contained in the dialysate collections (r = 0.798, p < 0.01).
CONCLUSIONS: The total amount of urinary excreted Klotho, but not the serum level of soluble Klotho, may be a potential biomarker for assessing the residual renal function among PD patients. Whether our findings are also valid for chronic kidney disease patients overall should therefore be evaluated in greater detail.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350461     DOI: 10.1007/s10157-011-0582-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  24 in total

1.  Severely reduced production of klotho in human chronic renal failure kidney.

Authors:  N Koh; T Fujimori; S Nishiguchi; A Tamori; S Shiomi; T Nakatani; K Sugimura; T Kishimoto; S Kinoshita; T Kuroki; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  2001-02-02       Impact factor: 3.575

2.  Factors affecting urine volume in chronic renal failure.

Authors:  D A Feinfeld; G M Danovitch
Journal:  Am J Kidney Dis       Date:  1987-09       Impact factor: 8.860

3.  Total body water volumes for adult males and females estimated from simple anthropometric measurements.

Authors:  P E Watson; I D Watson; R D Batt
Journal:  Am J Clin Nutr       Date:  1980-01       Impact factor: 7.045

4.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

Review 5.  Integrated end-stage renal disease care: the role of peritoneal dialysis.

Authors:  P G Blake
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

6.  Reduced hydration status characterized by disproportionate elevation of blood urea nitrogen to serum creatinine among the patients with cerebral infarction.

Authors:  Tetsu Akimoto; Chiharu Ito; Maki Kato; Manabu Ogura; Shigeaki Muto; Eiji Kusano
Journal:  Med Hypotheses       Date:  2011-07-20       Impact factor: 1.538

7.  Protein losses during peritoneal dialysis.

Authors:  M J Blumenkrantz; G M Gahl; J D Kopple; A V Kamdar; M R Jones; M Kessel; J W Coburn
Journal:  Kidney Int       Date:  1981-04       Impact factor: 10.612

Review 8.  Klotho.

Authors:  Makoto Kuro-o
Journal:  Pflugers Arch       Date:  2010-01       Impact factor: 3.657

9.  Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.

Authors:  J Bergström; P Fürst; A Alvestrand; B Lindholm
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

10.  Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis.

Authors:  R W van Olden; R T Krediet; D G Struijk; L Arisz
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

View more
  15 in total

1.  Renal Production, Uptake, and Handling of Circulating αKlotho.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Tayo Addo; Han Ju Cho; Sarah L Barker; Priya Ravikumar; Nancy Gillings; Ao Bian; Sachdev S Sidhu; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2015-05-14       Impact factor: 10.121

Review 2.  The emerging role of Klotho in clinical nephrology.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

3.  Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin.

Authors:  Francesca Leone; Danilo Lofaro; Paolo Gigliotti; Anna Perri; Donatella Vizza; Giuseppina Toteda; Simona Lupinacci; Filomena Armentano; Teresa Papalia; Renzo Bonofiglio
Journal:  J Nephrol       Date:  2014-04-24       Impact factor: 3.902

Review 4.  αKlotho and vascular calcification: an evolving paradigm.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

5.  The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody.

Authors:  Sarah L Barker; Johanne Pastor; Danielle Carranza; Henry Quiñones; Carolyn Griffith; Regina Goetz; Moosa Mohammadi; Jianfeng Ye; Jianning Zhang; Ming Chang Hu; Makoto Kuro-o; Orson W Moe; Sachdev S Sidhu
Journal:  Nephrol Dial Transplant       Date:  2014-10-15       Impact factor: 5.992

6.  Infection and smoking are associated with decreased plasma concentration of the anti-aging protein, α-klotho.

Authors:  Jennifer Lam-Rachlin; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Edgar Hernandez-Andrade; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

7.  Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation.

Authors:  Hyung Jung Oh; Bo Young Nam; Mi Jung Lee; Chan Ho Kim; Hyang Mo Koo; Fa Mee Doh; Jae Hyun Han; Eun Jin Kim; Ji Suk Han; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Dae-Suk Han; Seung Hyeok Han
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

8.  A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease.

Authors:  Masashi Kitagawa; Hitoshi Sugiyama; Hiroshi Morinaga; Tatsuyuki Inoue; Keiichi Takiue; Ayu Ogawa; Toshio Yamanari; Yoko Kikumoto; Haruhito Adam Uchida; Shinji Kitamura; Yohei Maeshima; Kazufumi Nakamura; Hiroshi Ito; Hirofumi Makino
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

9.  Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.

Authors:  Albina Nowak; Björn Friedrich; Ferruh Artunc; Andreas L Serra; Tobias Breidthardt; Raphael Twerenbold; Myriam Peter; Christian Mueller
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.

Authors:  Tetsu Akimoto; Hiromichi Yoshizawa; Yuko Watanabe; Akihiko Numata; Tomoyuki Yamazaki; Eri Takeshima; Kana Iwazu; Takanori Komada; Naoko Otani; Yoshiyuki Morishita; Chiharu Ito; Kazuhiro Shiizaki; Yasuhiro Ando; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  BMC Nephrol       Date:  2012-11-23       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.